Literature DB >> 27648615

Adipocyte-Lineage Cells Support Growth and Dissemination of Multiple Myeloma in Bone.

Timothy N Trotter1, Justin T Gibson1, Tshering Lama Sherpa1, Pramod S Gowda1, Deniz Peker1, Yang Yang2.   

Abstract

Multiple myeloma (MM) cells reside in the bone marrow microenvironment and form complicated interactions with nonneoplastic, resident stromal cells. We previously found that aggressive MM cells shift osteoblast progenitors toward adipogenesis. In addition, adipocytes are among the most common cell types in the adult skeleton; both mature adipocytes and preadipocytes serve as endocrine cells that secrete a number of soluble molecules into the microenvironment. Therefore, we used a combination of in vivo and in vitro methods to test the hypothesis that an increase in adipocyte lineage cells feeds back to promote MM progression. The results of this study revealed that bone marrow from patients with MM indeed contains increased preadipocytes and significantly larger mature adipocytes than normal bone marrow. We also found that preadipocytes and mature adipocytes secrete many molecules important for supporting MM cells in the bone marrow and directly recruit MM cells through both monocyte chemotactic protein-1 and stromal cell-derived factor-1α. Co-culture experiments found that preadipocytes activate Wnt signaling and decrease cleaved caspase-3, whereas mature adipocytes activate ERK signaling in MM cells. Furthermore, mature adipocyte conditioned medium promotes MM growth, whereas co-culture with preadipocytes results in enhanced MM cell chemotaxis in vitro and increased tumor growth in bone in vivo. Combined, these data reveal the importance of preadipocytes and mature adipocytes on MM progression and represent a unique target in the bone marrow microenvironment.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27648615      PMCID: PMC5222958          DOI: 10.1016/j.ajpath.2016.07.012

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  48 in total

Review 1.  The 5TMM series: a useful in vivo mouse model of human multiple myeloma.

Authors:  K Asosingh; J Radl; I Van Riet; B Van Camp; K Vanderkerken
Journal:  Hematol J       Date:  2000

2.  Insulin-like growth factor I is a dual effector of multiple myeloma cell growth.

Authors:  N L Ge; S Rudikoff
Journal:  Blood       Date:  2000-10-15       Impact factor: 22.113

Review 3.  Endocrinology of adipose tissue - an update.

Authors:  P Fischer-Posovszky; M Wabitsch; Z Hochberg
Journal:  Horm Metab Res       Date:  2007-05       Impact factor: 2.936

4.  Quantifying size and number of adipocytes in adipose tissue.

Authors:  Sebastian D Parlee; Stephen I Lentz; Hiroyuki Mori; Ormond A MacDougald
Journal:  Methods Enzymol       Date:  2014       Impact factor: 1.600

5.  Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.

Authors:  B Dankbar; T Padró; R Leo; B Feldmann; M Kropff; R M Mesters; H Serve; W E Berdel; J Kienast
Journal:  Blood       Date:  2000-04-15       Impact factor: 22.113

6.  Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease.

Authors:  S L Dallas; I R Garrett; B O Oyajobi; M R Dallas; B F Boyce; F Bauss; J Radl; G R Mundy
Journal:  Blood       Date:  1999-03-01       Impact factor: 22.113

7.  Heparanase stimulation of protease expression implicates it as a master regulator of the aggressive tumor phenotype in myeloma.

Authors:  Anurag Purushothaman; Ligong Chen; Yang Yang; Ralph D Sanderson
Journal:  J Biol Chem       Date:  2008-09-23       Impact factor: 5.157

8.  Proteasome inhibitor PS-341 abrogates IL-6 triggered signaling cascades via caspase-dependent downregulation of gp130 in multiple myeloma.

Authors:  Teru Hideshima; Dharminder Chauhan; Toshiaki Hayashi; Masaharu Akiyama; Nicholas Mitsiades; Constantine Mitsiades; Klaus Podar; Nikhil C Munshi; Paul G Richardson; Kenneth C Anderson
Journal:  Oncogene       Date:  2003-11-20       Impact factor: 9.867

9.  1,25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes.

Authors:  D Gao; P Trayhurn; C Bing
Journal:  Int J Obes (Lond)       Date:  2012-04-17       Impact factor: 5.095

Review 10.  Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation.

Authors:  Catherine M Kolf; Elizabeth Cho; Rocky S Tuan
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  29 in total

1.  Mesenchymal stem cells gene signature in high-risk myeloma bone marrow linked to suppression of distinct IGFBP2-expressing small adipocytes.

Authors:  Syed J Mehdi; Sarah K Johnson; Joshua Epstein; Maurizio Zangari; Pingping Qu; Antje Hoering; Frits van Rhee; Carolina Schinke; Sharmilan Thanendrarajan; Bart Barlogie; Faith E Davies; Gareth J Morgan; Shmuel Yaccoby
Journal:  Br J Haematol       Date:  2018-11-08       Impact factor: 6.998

Review 2.  Sclerostin: an Emerging Target for the Treatment of Cancer-Induced Bone Disease.

Authors:  Michelle M McDonald; Jesus Delgado-Calle
Journal:  Curr Osteoporos Rep       Date:  2017-12       Impact factor: 5.096

3.  Dual Effects of Melanoma Cell-derived Factors on Bone Marrow Adipocytes Differentiation.

Authors:  Juan Wang; Jin Wen; Xiao-Xiang Chen; Guang-Liang Chen
Journal:  J Vis Exp       Date:  2018-08-23       Impact factor: 1.355

4.  Development of a 3D bone marrow adipose tissue model.

Authors:  Heather Fairfield; Carolyne Falank; Mariah Farrell; Calvin Vary; Joshua M Boucher; Heather Driscoll; Lucy Liaw; Clifford J Rosen; Michaela R Reagan
Journal:  Bone       Date:  2018-01-31       Impact factor: 4.398

5.  Myeloma cells shift osteoblastogenesis to adipogenesis by inhibiting the ubiquitin ligase MURF1 in mesenchymal stem cells.

Authors:  Zhiqiang Liu; Huan Liu; Jin He; Pei Lin; Qiang Tong; Jing Yang
Journal:  Sci Signal       Date:  2020-05-26       Impact factor: 8.192

Review 6.  The role of bone marrow adipocytes in cancer progression: the impact of obesity.

Authors:  Marine Hernandez; Sauyeun Shin; Catherine Muller; Camille Attané
Journal:  Cancer Metastasis Rev       Date:  2022-06-16       Impact factor: 9.237

Review 7.  Lipids in the Bone Marrow: An Evolving Perspective.

Authors:  Elizabeth Rendina-Ruedy; Clifford J Rosen
Journal:  Cell Metab       Date:  2019-10-24       Impact factor: 27.287

8.  Reflections on Cancer in the Bone Marrow: Adverse Roles of Adipocytes.

Authors:  Carolyne Falank; Heather Fairfield; Michaela R Reagan
Journal:  Curr Mol Biol Rep       Date:  2017-10-19

Review 9.  Targeting Reactive Oxygen Species Metabolism to Induce Myeloma Cell Death.

Authors:  Mélody Caillot; Hassan Dakik; Frédéric Mazurier; Brigitte Sola
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

10.  Myeloma-Modified Adipocytes Exhibit Metabolic Dysfunction and a Senescence-Associated Secretory Phenotype.

Authors:  Andre J van Wijnen; Abbas Jafari; Michaela R Reagan; Heather Fairfield; Amel Dudakovic; Casper M Khatib; Mariah Farrell; Samantha Costa; Carolyne Falank; Maja Hinge; Connor S Murphy; Victoria DeMambro; Jessica A Pettitt; Christine W Lary; Heather E Driscoll; Michelle M McDonald; Moustapha Kassem; Clifford Rosen; Thomas L Andersen
Journal:  Cancer Res       Date:  2020-11-20       Impact factor: 13.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.